P Passadakis
Overview
Explore the profile of P Passadakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katergari S, Milousis A, Mantatzis M, Gioka T, Tripsianis G, Passadakis P, et al.
Minerva Endocrinol
. 2014 Apr;
39(2):107-17.
PMID: 24736485
Aim: Differences in fat accumulation and distribution might be responsible for the greater insulin resistance (IR) in type 2 diabetes. The study aims at examining the relationship between fat accumulation...
2.
Vagiona A, Koupidis S, Passadakis P, Thodis E, Vargemezis V
Hippokratia
. 2013 Aug;
16(2):154-8.
PMID: 23935271
Background: Twenty four-hour ambulatory blood pressure (BP) monitoring (ABPM) is being increasingly used to evaluate the effectiveness of antihypertensive medications. We aimed to to investigate the incidence of "non-dippers" in...
3.
Kantartzi K, Panagoutsos S, Kokkinou V, Alepopoulou E, Mourvati E, Passadakis P, et al.
Clin Nephrol
. 2010 Apr;
73(4):309-13.
PMID: 20353739
Background: Brucellosis is a zoonotic disease transmittable to humans. It is diagnosed either by isolation of Brucella organism in culture of blood or other sample types (e.g., bone marrow or...
4.
Kriki P, Thodis E, Deftereos S, Panagoutsos S, Theodoridis M, Kantartzi K, et al.
Clin Nephrol
. 2009 May;
71(6):714-8.
PMID: 19473642
Though pulmonary tuberculosis (TBC) remains the commonest clinical presentation, extrapulmonary TBC is an increasingly important clinical problem. Among the extrapulmonary sites, primary liver tuberculosis seems to be an extremely rare...
5.
Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, et al.
Ren Fail
. 2008 Feb;
30(2):161-7.
PMID: 18300115
Background: The importance to maintain the peritoneal membrane integrity for peritoneal dialysis (PD) patients by using biocompatible solutions (with low or no glucose as osmotic factor and low in glucose...
6.
Kalaitzis C, Passadakis P, Giannakopoulos S, Panagoutsos S, Mpantis E, Triantafyllidis A, et al.
Int Urol Nephrol
. 2006 Dec;
39(3):743-6.
PMID: 17180736
Introduction: Indinavir, a protease inhibitor that is commonly used to treat HIV infection, may cause crystal formation within the renal tubules when urine pH is above 3.5. Crystallization in the...
7.
Verettas D, Ververidis A, Boyiatzis C, Panagoutsos S, Galanis V, Passadakis P, et al.
Clin Nephrol
. 2006 Apr;
65(4):299-302.
PMID: 16629232
Tuberculosis of the spine is not rare in immunocompromised patients and particularly in those with end-stage renal disease (ESRD). Furthermore, the possible vascular compromise of the spinal cord in patients...
8.
Panagoutsos S, Kantartzi K, Passadakis P, Yannatos E, Mourvati E, Theodoridis M, et al.
Clin Nephrol
. 2006 Jan;
65(1):43-7.
PMID: 16429841
Aims: The two main renal replacement therapies (RRT)--hemodialysis (HD) and peritoneal dialysis (PD)--have been considered to be antagonistic in most published studies on the clinical outcomes of dialysis patients. Recently,...
9.
Kantartzi K, Passadakis P, Polychronidis A, Perente S, Vargemezis V, Simopoulos C
Perit Dial Int
. 2005 Jun;
25(3):295-6.
PMID: 15981781
No abstract available.
10.
Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos D
Int J Artif Organs
. 2003 Oct;
26(8):698-714.
PMID: 14521167
Catheter-related infections, exit-site-tunnel infections and peritonitis remain the Achilles heel of peritoneal dialysis. Although the overall incidence of peritoneal-dialysis-related infectious complications has been reduced since the introduction of the Y-set...